We are live on ! Find out more
PHP

Parkman Healthcare Partners Portfolio holdings

AUM $970M
1-Year Est. Return 79.46%
This Fund
S&P 500
This Quarter Est. Return
-3.84%
1 Year Est. Return
+79.46%
3 Year Est. Return
+312.89%
5 Year Est. Return
+648.59%
10 Year Est. Return
–
AUM
$546M
AUM Growth
-$31.1M
Cap. Flow
+$46.9M
Cap. Flow %
8.6%
Top 10 Hldgs %
37.26%
Holding
117
New
22
Increased
53
Reduced
27
Closed
15

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$20.3M
2
HCA icon
HCA Healthcare
HCA
+$15.4M
3
COO icon
Cooper Companies
COO
+$9.29M
4
CRL icon
Charles River Laboratories
CRL
+$9.07M
5
ZBH icon
Zimmer Biomet
ZBH
+$9.02M

Top Sells

Rank Stock Value
1
DHR icon
Danaher
DHR
+$14.6M
2
LNTH icon
Lantheus
LNTH
+$14.3M
3
WAT icon
Waters Corp
WAT
+$10.8M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$5.89M
5
SDGR icon
Schrodinger
SDGR
+$4.59M

Sector Composition

Rank Sector Weight
1 Healthcare 99.65%
2 Industrials 0.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IONS icon
26
Ionis Pharmaceuticals
IONS
$9.39B
$7.24M 1.33%
159,503
+6,451
+4% +$266K
VRNA
27
DELISTED
Verona Pharma
VRNA
$6.81M 1.25%
417,933
+16,946
+4% +$326K
PODD icon
28
Insulet
PODD
$10.1B
$6.7M 1.23%
42,025
-16,026
-28% -$3.59M
ANIP icon
29
ANI Pharmaceuticals
ANIP
$1.73B
$6.49M 1.19%
111,802
-62,675
-36% -$3.62M
AKRO
30
DELISTED
Akero Therapeutics
AKRO
$5.87M 1.08%
116,107
+81,107
+232% +$3.78M
DAWN
31
DELISTED
Day One Biopharmaceuticals
DAWN
$5.72M 1.05%
466,408
+38,129
+9% +$497K
ETNB
32
DELISTED
89bio
ETNB
$5.61M 1.03%
363,553
+14,678
+4% +$246K
AMGN icon
33
Amgen
AMGN
$225B
$5.38M 0.98%
+20,000
New +$4.99M
INSP icon
34
Inspire Medical Systems
INSP
$1.68B
$5.34M 0.98%
26,923
+12,453
+86% +$3.14M
TVTX icon
35
Travere Therapeutics
TVTX
$5.86B
$5.16M 0.95%
577,494
+431,171
+295% +$6.08M
VCYT icon
36
Veracyte
VCYT
$3.59B
$5.04M 0.92%
225,872
+13,912
+7% +$358K
APLT
37
DELISTED
Applied Therapeutics
APLT
$4.36M 0.8%
+1,750,000
New +$2.88M
STRO icon
38
Sutro Biopharma
STRO
$353M
$4.1M 0.75%
118,217
+3,831
+3% +$167K
CGEM icon
39
Cullinan Oncology
CGEM
$1.26B
$3.97M 0.73%
438,745
+91,964
+27% +$958K
SUPN icon
40
Supernus Pharmaceuticals
SUPN
$2.78B
$3.81M 0.7%
138,172
-52,007
-27% -$1.58M
CSTL icon
41
Castle Biosciences
CSTL
$960M
$3.79M 0.7%
224,592
+76,590
+52% +$1.34M
SILK
42
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$3.74M 0.68%
249,341
-58,184
-19% -$1.21M
RCUS icon
43
Arcus Biosciences
RCUS
$3.69B
$3.68M 0.67%
205,109
+85,060
+71% +$1.71M
CTLT
44
DELISTED
CATALENT, INC.
CTLT
$3.67M 0.67%
80,646
-60,604
-43% -$2.83M
IDYA icon
45
IDEAYA Biosciences
IDYA
$3.56B
$3.58M 0.66%
132,701
+5,362
+4% +$136K
LNTH icon
46
Lantheus
LNTH
$6.57B
$3.47M 0.64%
49,889
-195,658
-80% -$14.3M
CVRX icon
47
CVRx
CVRX
$72.7M
$3.37M 0.62%
222,120
+81,357
+58% +$1.34M
SIBN icon
48
SI-BONE Inc
SIBN
$852M
$3.29M 0.6%
155,046
+16,131
+12% +$374K
INSM icon
49
Insmed
INSM
$28.9B
$3.16M 0.58%
+125,000
New +$2.86M
SNDX icon
50
Syndax Pharmaceuticals
SNDX
$1.77B
$3.08M 0.57%
212,448
+4,182
+2% +$79.1K
1
2
3 4 5

Similar funds

LOIM
Liberty One Investment Management Libertyville, Illinois $970M AUM 12.15% 1-Year Est. Return
MGCM
Mane Global Capital Management New York $971M AUM 58.5% 1-Year Est. Return
JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
WAM
WNY Asset Management Williamsville, New York $967M AUM
GHC
Graham Holdings Company Arlington, Virginia $967M AUM 15.12% 1-Year Est. Return
SAM
Stansberry Asset Management Westlake, Texas $973M AUM 21.39% 1-Year Est. Return
TCCM
Two Creeks Capital Management New York $974M AUM 2.54% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Parkman Healthcare Partners's Q3 2023 Portfolio in Review

As of Q3 2023, Parkman Healthcare Partners held 117 positions worth $546M, down 5.4% from $577M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Parkman Healthcare Partners deployed $46.9M of net new capital in Q3 2023, opening 22 new positions and adding to 53 existing holdings. Its largest new stake was HCA Healthcare: 56,160 shares worth $13.8M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 99% a quarter earlier, followed by Industrials.

On the sell side, the largest reduction was Lantheus, an estimated $14.3M trimmed.

  • Parkman Healthcare Partners's largest Q3 2023 buy was HCA Healthcare: 56,160 shares worth $13.8M.
  • Parkman Healthcare Partners added most to DexCom in Q3 2023, an estimated $20.3M increase.
  • Parkman Healthcare Partners's biggest Q3 2023 reduction was Lantheus, cutting an estimated $14.3M.
  • Parkman Healthcare Partners fully exited Danaher in Q3 2023, selling an estimated $14.6M.
  • Parkman Healthcare Partners's ten largest holdings make up 37% of its $546M portfolio in Q3 2023.
  • Parkman Healthcare Partners opened 22 new positions and closed 15 in Q3 2023.
  • Parkman Healthcare Partners's portfolio value fell 5.4% quarter-over-quarter to $546M.

Based on Parkman Healthcare Partners's 13F filing for Q3 2023, filed 14 Nov 2023.